Chevron
CVX
The Kroger
KR
Occidental Petroleum
OXY
DaVita
DVA
Coca-Cola
KO
US Stock MarketDetailed Quotes
SRPT Sarepta Therapeutics
- 124.790
- -1.480-1.17%
Close Jan 10 16:00 ET
- 125.700
- +0.910+0.73%
Pre 08:52 ET
11.92BMarket Cap81.03P/E (TTM)
128.750High123.500Low760.72KVolume124.750Open126.270Pre Close95.41MTurnover0.84%Turnover RatioLossP/E (Static)95.52MShares173.25052wk High9.76P/B11.37BFloat Cap102.15552wk Low--Dividend TTM91.15MShs Float181.830Historical High--Div YieldTTM4.16%Amplitude2.598Historical Low125.417Avg Price1Lot Size
Sarepta Therapeutics News
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Wigzell Hans Lennart Rudolf
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Boor Kathryn Jean
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rothfuss Cristin
Sarepta Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Rothfuss Cristin
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Janus Henderson Group plc(4.6%)
Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Capital International Investors(6.7%)
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Connelly Deirdre P
Sarepta Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Connelly Deirdre P
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Chambers Michael Andrew
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BEHRENS M KATHLEEN
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Brown Ryan Edward
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Rodino-Klapac Louise
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Murray Dallan
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Estepan Ian Michael
Sarepta Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Arif Bilal
Sarepta Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(10.7%)
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.